...
首页> 外文期刊>Medicine. >Percutaneous endoscopic decompression for lumbar spinal stenosis: Protocol for a systematic review and network meta-analysis
【24h】

Percutaneous endoscopic decompression for lumbar spinal stenosis: Protocol for a systematic review and network meta-analysis

机译:腰椎狭窄的经皮内镜减压:系统审查和网络元分析的协议

获取原文
           

摘要

Background: Lumbar spinal stenosis (LSS) is a common and frequently-occurring disease in clinical practice. There are many interventions to treat it, and percutaneous endoscopic decompression (PED) is one of them, but their relative efficacy and safety remains unclear. Hence, the present study aims to synthesize the available direct and indirect evidence on the PED and other treatments for LSS. Methods: The following databases will be searched: Cochrane Library, PubMed, Web of Science, Embase and China Biomedical Literature Database (CBM). The search dates will be set from the inception to April 2019. All randomized controlled trials (RCTs) will be included in this network meta-analysis (NMA) and their risk of bias will be assessed using Cochrane handbook tool by 2 independent authors. The efficacy outcomes including: Back and Leg Visual Analog Scale (VAS) score, MacNab criteria, the Oswestry Disability Index (ODI), and Japanese Orthopedic Association (JOA) score. The safety outcomes including: incidence of complications (dura tear, incomplete decompression, reoperation, etc.). A network meta-analysis will be performed using R x64 3.5.1 software and pairwise meta-analysis will be conducted using Stata 12.0 software. Grading of recommendations assessment, development, and evaluation (GRADE) will be used to assess evidence quality. Results: The results of NMA will be submitted to a peer-reviewed journal. Conclusion: The NMA will provide a comprehensive evidence summary on treatments for patients with LSS. Protocol registration number: CRD42019120509.
机译:背景:腰椎狭窄(LSS)是临床实践中常见而常见的疾病。治疗它有许多干预措施,并且经皮内窥镜减压(PED)是其中之一,但它们的相对功效和安全性仍然尚不清楚。因此,本研究旨在将可用的直接和间接证据合成了LSS的PED和其他治疗方法。方法:将搜索以下数据库:Cochrane Library,PubMed,Science,Embase和中国生物医学文献数据库(CBM)。搜索日期将从开始到2019年4月。所有随机对照试验(RCT)将包含在该网络中,将使用2名独立作者使用Cochrane手册工具进行评估其偏差风险。疗效结果包括:后退和腿视觉模拟规模(VAS)得分,麦克纳布标准,oswestry残疾指数(ODI)和日本矫形协会(JOA)得分。安全结果包括:并发症发生率(Dura撕裂,不完全减压,重新组合等)。将使用R X64 3.5.1软件进行网络元分析,并使用Stata 12.0软件进行成对元分析。建议评估,发展和评估(等级)的分级将用于评估证据质量。结果:NMA的结果将提交给同行评审日志。结论:NMA将为LSS患者提供全面的证据总结。协议注册号:CRD42019120509。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号